CCEL Q2 2020 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q2 2020 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M-3.1% YoY

Gross Profit

$5M68.5% margin

Operating Income

$2M22.3% margin

Net Income

$953,33812.1% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

$822,192

Free Cash Flow

$778,925

Stock-Based Comp.

$64,494

Balance Sheet

Total Assets

$45M

Total Liabilities

$50M

Stockholders' Equity

-$5M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	-3.1%
Gross Profit	$5M	$5M	-2.0%
Operating Income	$2M	$496,564	+252.9%
Net Income	$953,338	$53,673	+1676.2%

Revenue Segments

Processing and Storage Fees

$7M94%

Public Banking

$213,6423%

Licensee And Royalty Income Recognition

$201,8283%

Product

$57,3001%

Geographic Segments

INDIA

$201,828100%